Unusual cases and rare leukemias
Chairs:
Dr. Mayte Olaveo
Hospital Clínico Universitario Lozano Blesa. Zaragoza, España
Dr. Josefina Serrano
Hospital Universitario Reina Sofía. Córdoba, España
Expert:
Dr. Guillermo Garcia-Manero
MD Anderson Cancer Center, Houston, EEUU
Chairs:
Dr. Miguel Ángel Sanz
Hospital Universitario y Politécnico La Fe. Valencia, España
Dr. Adolfo de la Fuente
MD Anderson Cancer Center Madrid, España
11:40 - 12:00The role of FLT3 tyrosine kinase receptor in acute myeloid leukemia: biology and clinical implications
Dr. Eva Barragán
Hospital Universitario y Politécnico La Fe. Valencia, España
12:00 - 12:20The role of FLT3 inhibitors in induction therapy
Dr. Marina Díaz Beyá
Hospital Clínic. Barcelona, Spain
12:20 - 12:40Targeting FLT3 in salvage therapy
Dr. Pau Montesinos
Hospital Universitario y Politécnico La Fe. Valencia, España
12:40 - 12:55Discussion
Chairs:
Dr. Adolfo de la Fuente
MD Anderson Cancer Center Madrid, España
Dr. Pau Montesinos
Hospital Universitario y Politécnico La Fe. Valencia, España
12:55 - 13:15FLT3 Induction therapy in Spain
Dr. Mar Tormo
Hospital Clínico Universitario de Valencia, España
13:15 - 13:35FLT3 positive AML in USA
Dr. Naval Daver
MD Anderson Cancer Center, Houston, EEUU
13:35 - 13:55FLT3 positive AML in Italy
Dr. Alessandro Isidori
Hematology and Stem Cell Transplant Center AORMN Hospital. Pesaro, Italy
13:55 - 14:10Discussion